These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-004618-18 SUBLIVAC® study on the safety of an initial phase rush-in with the use of a compliance friendly one bottle concept. 2006-06-26 due-trials
Reported results 2005-002859-41 Open-label, blinded endpoint, randomized, parallel treatment study to compare the clinical efficacy of PURETHAL® Bee and Alutard SQ Bee. 2008-12-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005175-16 Twin SUBLIVAC® Grasses Clinical Efficay Study 2009-10-07 bad-data
Completed, but no date, and reported results 2008-006261-81 Dose Tolerability Study with High Dose PURETHAL Mites in Allergic Rhinitis / Rhinoconjunctivitis Patients. An open study to assess tolerability, safety and short-term efficacy of high dose PURETHAL M... bad-data
Reported results 2008-006292-77 SUBLIVAC® Birch PROBE study 2010-03-02 due-trials
Reported results 2009-015012-18 A prospective, randomized, open, multi-centre study to assess safety of PURETHAL Grasses given with a rush induction schedule to patients with allergic rhinoconjunctivitis. 2010-08-24 due-trials
Reported results 2010-021235-13 A randomized, double-blind, placebo-controlled study to determine safety, tolerability and the optimal effective dose of SUBLIVAC FIX Phleum pratense in patients with allergic rhinitis/rhinoconjunctiv... 2013-06-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000393-61 A multi-centre, randomized, double-blind, placebo-controlled, dose range finding study to identify the optimal (i.e. safe and effective) dose of PURETHAL® Mites SCIT in patients with house dust mites-... 2013-05-15 bad-data
Reported results 2011-004550-25 A randomized, double-blind, placebo-controlled study to determine safety, tolerability and the optimal effective dose of SUBLIVAC FIX Birch in patients with allergic rhinitis/rhinoconjunctivitis cause... 2013-05-30 due-trials
Reported results 2013-000086-36 A prospective, randomized, open, multi-centre study to assess safety of PURETHAL Birch given with a rush up-dosing regimen to patients with allergic rhinitis/rhinoconjunctivitis. 2014-03-28 due-trials
Reported results 2013-005550-30 A randomized, double-blind, placebo-controlled (DBPC), parallel group study to assess the clinical efficacy and safety of SUBLIVAC FIX Birch immunotherapy in patients suffering from allergic rhinitis/... 2016-02-03 due-trials
Ongoing, reported early 2014-002047-18 A randomized, double-blind, placebo-controlled study to determine tolerability and safety of different dosages of SUBLIVAC FIX Mite mixture in patients with allergic rhinitis / rhinoconjunctivitis cau... not-yet-due
Not reported 2016-000051-27 A randomized, double-blind, placebo-controlled (DBPC) parallel-group multi-centre study to assess the efficacy and safety of PURETHAL Mites subcutaneous immunotherapy (SCIT) in patients with allergic ... 2018-04-23 due-trials